A structure-guided optimization of pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of EGFR(L858R/T790M) mutant with improved pharmacokinetic properties.
Yu, L., Huang, M., Xu, T., Tong, L., Yan, X.E., Zhang, Z., Xu, Y., Yun, C., Xie, H., Ding, K., Lu, X.(2017) Eur J Med Chem 126: 1107-1117
- PubMed: 28033579 
- DOI: 10.1016/j.ejmech.2016.12.006
- Primary Citation of Related Structures:  
5GMP - PubMed Abstract: 
Structural optimization of pyrido[2,3-d]pyrimidin-7-ones was conducted to yield a series of new selective EGFR T790M inhibitors with improved pharmacokinetic properties. One of the most promising compound 9s potently suppressed EGFR L858R/T790M kinase and inhibited the proliferation of H1975 cells with IC 50 values of 2 ...